Login / Signup

Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: An Integrative Literature Review.

Grace E FoxMark BernauerJennifer M StephensBianca JacksonJoshua A RothAhmed Shelbaya
Published in: ClinicoEconomics and outcomes research : CEOR (2024)
To our knowledge, this is the first study to systematically assess and create a framework for biosimilar portfolio value. The conceptual framework described here could be tested to quantify the clinical and economic value associated with a biosimilar portfolio.
Keyphrases
  • healthcare